There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (06/06/1996)

Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.